2-(Diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine

Catalog No. :
ACXZMH083
CAS No. :
201275-29-8
Molecular Formula :
C20H16N3P
Molecular Weight :
329.34

IUPAC Name:2-(diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine

2-(Diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00Login to see priceIn stockIn stock
1g95%$169.00Login to see priceIn stockIn stock
5g95%$554.00Login to see priceIn stockIn stock
25g95%$2150.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine
IUPAC Name2-(diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine
Molecular FormulaC20H16N3P
Molecular Weight329.34
SMILESC1=CC=C(P(C2=CC=CC=C2)C2=NC(N3C=CC=N3)=CC=C2)C=C1
InChI KeyVRKWGVLOTOLMAH-UHFFFAOYSA-N
SynonymPyridine, 2-(diphenylphosphino)-6-(1H-pyrazol-1-yl)-;2-(diphenylphosphino)-6-(pyrazol-1-yl)pyridine;2-(Diphenylphosphaneyl)-6-(1H-pyrazol-1-yl)pyridine
CAS No.201275-29-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335-H413
Precautionary Statement(s)
P261-P264-P271-P273-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXZMH083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZMH083 route product structure diagram
    ACXZMH083201275-29-8 In Stock
Inquiry

2. ACXZMH083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZMH083 route product structure diagram
    ACXZMH083201275-29-8 In Stock
Inquiry

Comments (0)